newsfilter
← Latest News
GlobeNewswire·

Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

WATERTOWN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (NASDAQ:ACRV), a clinical stage precision medicine company utilizing its Acrivon Precision Predictive